Pfizer Begins Phase 1 of Pediatric Testing for their Coronavirus Vaccine
Researchers at Duke University have begun testing Pfizer’s Covid-19 vaccine in children under the age of 12. Yesterday the company said that at least 2 children have already received their first shot. It intends to enroll 144 children in Phase 1. During the first phase, the company will identify the preferred dosage level for three age groups: between 6 months…
